Close
Digital Health & Ai Innovation summit 2026
Medical Taiwan 2026

Co-Diagnostics, Inc Completes Successful Clinical Evaluation Required for FDA Emergency Use Authorization

Co-Diagnostics, Inc Completes Successful Clinical Evaluation Required for FDA Emergency Use Authorization

Co-Diagnostics, Inc. , a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests, announced that following a successful clinical evaluation of its Logix Smart™ COVID-19 Test, the Company will begin fulfilling orders from a wider array of U.S. customers, including thousands of additional laboratories in the country who can now run the Company’s test as a clinical diagnostic.

A recent FDA policy change aimed at expediting the availability of COVID-19 diagnostics has allowed the Company to expand domestic sales of its test immediately. Co-Diagnostics’ COVID-19 polymerase chain reaction (PCR) test can yield results in under two hours, and successfully passed the clinical evaluation as requested in the policy change, showing sensitivity of 100% and specificity of 100% in detecting SARS-CoV-2, the virus which causes COVID-19, without demonstrating any cross-reactivity with other coronaviruses.

Dwight Egan, Co-Diagnostics CEO, commented “Our Logix Smart COVID-19 test has already been deployed on a global basis to five continents as well as to U.S. CLIA labs that meet certain requirements, and we are prepared to provide an even greater number of U.S. laboratories and patients access to our test as a result of the new FDA policy. The demand for reliable, high-quality COVID-19 diagnostics has never been greater, and it continues to grow daily as this disease affects not just patients afflicted with it and their families, but the entire nation as a whole.

“We believe the excellent performance of our COVID-19 test combined with affordable pricing will place it in the vanguard of available testing alternatives worldwide. We have scaled up both our domestic and international production capabilities to meet demand, including receiving a license to manufacture our COVID-19 test in our facility in India, which more than triples our capacity. The Company’s Logix Smart COVID-19 test, built on our patented CoPrimer™ technology, has the potential to improve the quality of life of millions of Americans by providing access to a prompt, accurate, cost-effective test. We are gratified to be in a position to make available a test that can provide results in less than two hours, which we believe is among the fastest turn-around times of any test currently on the market.”

The new FDA policy permits Co-Diagnostics to begin U.S. sales of COVID-19 tests immediately while it awaits FDA clearance under Emergency Use Authorization (EUA). The Company’s application for EUA is currently under review by the FDA.

Honeywell Expands Face Mask Production with New Manufacturing Operations in Smithfield, Rhode Island

Honeywell Expands Face Mask Production with New Manufacturing Operations in Smithfield, Rhode Island

Honeywell announced that it will immediately expand its manufacturing operations in Smithfield, Rhode Island, to produce N95 face masks in support of the U.S. government’s response to the novel coronavirus (COVID-19).

Honeywell is ramping up operations to produce millions of N95 disposable respirators to help support the need for critical safety equipment.

“We are honored to support the U.S. government’s efforts to protect Americans with personal protective equipment made right here in the United States,” said Darius Adamczyk, Honeywell chairman and chief executive officer. “Our Rhode Island facility already produces industry-leading safety gear and soon will play a critical role in supplying the Strategic National Stockpile with N95 masks.”

Honeywell anticipates that the addition of the new mask production line in Smithfield will create at least 500 new jobs. The company will begin recruiting, hiring and training manufacturing workers immediately.

The N95 face masks will be delivered to the U.S. Department of Health and Human Services to contribute to the American stockpile for use to support health, safety and emergency response workers.

Honeywell’s production expansion will support additional American businesses that are part of the supply chain, including industrial equipment providers and raw materials suppliers. The company is also actively collaborating with state and local officials to ramp up production efforts and support recruiting and training for workers.

Honeywell’s Smithfield factory was established in 1980 and produces UVEX-branded eye protection products, which include safety glasses, safety goggles and protective face shields.

Honeywell is an industry-leading provider of intelligent safety solutions and personal protective equipment that help organizations keep their workers safe and healthy on the job. The company’s offerings include hazardous gas detectors, safety software solutions and personal protective equipment such as gloves, protective eyewear, respiratory protection, safety suits, hard hats and boots.

Honeywell is a Fortune 100 technology company that delivers industry-specific solutions that include aerospace products and services; control technologies for buildings and industry; and performance materials globally. Our technologies help aircraft, buildings, manufacturing plants, supply chains, and workers become more connected to make our world smarter, safer, and more sustainable.

Magellan Health Expands Telehealth Services to Support Clients during COVID-19 Outbreak

Magellan Health, Inc. announced that Magellan Healthcare, the behavioral and specialty healthcare segment of the company, has expanded telehealth services and implemented additional initiatives to help support clients during the novel coronavirus (COVID-19) pandemic.

“As we continue to respond to issues concerning COVID-19, behavioral health services are more important now than ever, and continuity of care is paramount as people cope with uncertainty and anxiety about the outbreak,” said Matthew Miller, senior vice president, behavioral health, Magellan Healthcare.

As the Centers for Medicare & Medicaid Services (CMS) and the U.S. Department of Health and Human Services (HHS) Office for Civil Rights (OCR) guidance came out on Tuesday, Magellan was revising its operations to permit all credentialed and contracted behavioral health providers to conduct telehealth video sessions for all routine services and certain psychological testing, applied behavior analysis (ABA), intensive outpatient programs (IOP) and partial hospitalization program (PHP) services. Providers are able to use a number of HHS OCR-approved platforms to conduct their telehealth video sessions. Magellan is also allowing telephone-only sessions when a member has no access to a video platform. These alternative approaches will be covered to ensure members get the care they need, when they need it.

“Our experienced behavioral health network providers are available to serve the needs of our clients’ members through a variety of avenues. We are proud of our network providers and look forward to working with them to support those who may need mental health services as a result of the COVID-19 outbreak,” said Miller.

About Magellan Healthcare: Magellan Healthcare, Inc., the healthcare business unit of Magellan Health, Inc., offers solutions for complex conditions in the areas of behavioral health, medical specialty treatment and fully integrated managed care. Magellan Healthcare serves commercial health plans, employers, state and local governments, and the Federal government, including the Department of Defense. For more information, visit MagellanHealthcare.com.

About Magellan Health: Magellan Health, Inc., a Fortune 500 company, is a leader in managing the fastest growing, most complex areas of health, including special populations, complete pharmacy benefits and other specialty areas of healthcare. Magellan supports innovative ways of accessing better health through technology, while remaining focused on the critical personal relationships that are necessary to achieve a healthy, vibrant life. Magellan’s customers include health plans and other managed care organizations, employers, labor unions, various military and governmental agencies and third-party administrators.

Precision Spine Launches Nationally the SureLOK MIS 3L Percutaneous Screw System

Precision Spine Launches Nationally the SureLOK MIS 3L Percutaneous Screw System

Precision Spine, Inc., a medical device company dedicated to Made-in-the-USA manufacturing, has nationally launched the SureLOK MIS 3L Percutaneous Screw System,which provides spine surgeons with outstanding versatility and flexibility in terms of procedural approaches and application of its various components

“The inherent versatility of the SureLOK MIS3L System enables it to be used in Open, Mini-Open or Percutaneous MIS approaches, or even a combination of any of those approaches during the same procedure,” said Phillip Kravetz, MD,who worked with the Precision Spine design team in the development of the system. “This flexibility provides surgeons with a range of options intended to optimize efficiency and effectiveness in both planning and performing successful spinal procedures.”

Component versatility is another key element of the SureLOK MIS 3L System, which consists of cannulated pedicle screws, straight and pre-curved rods, and locking caps, all of which are available in a variety of sizes that enable surgeons to more closely match each patient’s anatomy. The screws feature a 150mm Extended Tab designed to allow for low profile, MIS Percutaneous placement with 50mm of controlled rod reduction. In addition, an Open Tulip design helps ease rod introduction while the proximal tapered triple lead thread helps enhance efficiency in placing screw sand optimize pull-out strength. The screw’s self-tapping tip is designed to help ease insertion and a square thread locking cap assists in reducing the potential for cross threading. The system’s easy-to-use percutaneous rod inserter features a bulleted tip, keyed hex end and 15°rod angle which helps ease rod insertion and release; the inserter shaft is designed to glide easily through the tulips for fast and efficient rod delivery.The system also includes a reliable compression/distraction system.

The indications of the SureLOK MIS 3L System provide further versatility. The system can be used in the immobilization and stabilization of spinal segments in skeletally mature patients as an adjunct to fusion in the treatment of acute and chronic instabilities or deformities of the thoracic, lumbar and sacral spine. It may also be used for non-cervical pedicle screw fixation for severe spondylolisthesis, trauma, spinal stenosis, curvatures, spinal tumor, pseudarthrosis and failed previous fusion.

“The SureLOK MIS 3L Percutaneous Screw System represents another example of how Precision Spine is making good on its commitment to develop minimally invasive devices that feature the versatility and flexibility surgeons need to help improve OR efficiency and achieve positive patient outcomes,” said Chris DeNicola, Chief Operating Officer of Precision Spine.

About Precision Spine

Precision Spine, Inc. is a privately held company headquartered in Parsippany, NJ with manufacturing facilities in Pearl, MS. Precision Spine is dedicated to providing innovative, quality spine products that are made in the USA and designed to help treat serious orthopedic medical conditions in a cost-effective manner.

Canon Medicals 3T MR System Receives FDA Clearance for AI Based Image Reconstruction Technology

Canon Medicals 3T MR System Receives FDA Clearance for AI Based Image Reconstruction Technology

Canon Medical Systems USA, Inc. has received 510(k) clearance on its Advanced intelligent Clear-IQ Engine (AiCE) for the Vantage Galan 3T MR system, further expanding access to its new Deep Learning Reconstruction (DLR) technology. This technology, which is also available across a majority of Canon Medical’s CT product portfolio, uses a deep learning algorithm to differentiate true MR signal from noise so that it can suppress noise while enhancing signal, forging a new frontier for MR image reconstruction.

AiCE was trained using vast amounts of high-quality image data, and features a deep learning neural network that can reduce noise and boost signal to quickly deliver sharp, clear and distinct images, further opening doors for advancements in MR imaging. Capabilities include:

High quality images: AiCE allows for the differentiation of true signal from noise through deep learning innovation to match the spatial resolution and low-noise properties of advanced scanning and reconstruction, while maintaining the true structure of the anatomy.
Seamless integration into routine practice: AiCE is the world’s first fully integrated deep learning reconstruction for MR, and is built directly into the scan protocols for seamless workflow.
Preferred AiCE MR image quality over non-AI reconstruction images: Following a blinded image comparison of AiCE DLR reconstructed images with images reconstructed with conventional methods without AiCE, physicians stated preference for AiCE images for clarity and resolution.

“AiCE utilizes a next generation approach to MR image reconstruction, further proving Canon Medical’s leadership and commitment to innovation in diagnostic imaging,” said Jonathan Furuyama, managing director, MR Business Unit, Canon Medical Systems USA, Inc. “With the expansion of this unique DLR method across modalities and into MR, we’re elevating diagnostic imaging capabilities for our customers by bringing the power of AI to routine imaging to provide more possibilities in improving patient care than ever before.”

About Canon Medical Systems USA, Inc.

Canon Medical Systems USA, Inc., headquartered in Tustin, Calif., markets, sells, distributes and services radiology and cardiovascular systems, including CT, MR, ultrasound, X-ray and interventional X-ray equipment.

About Canon Medical Systems Corporation

Canon Medical offers a full range of diagnostic medical imaging solutions including CT, X-Ray, Ultrasound, Vascular and MR, as well as a full suite of Healthcare IT solutions, across the globe. In line with our continued Made for Life philosophy, patients are at the heart of everything we do. Our mission is to provide medical professionals with solutions that support their efforts in contributing to the health and wellbeing of patients worldwide. Our goal is to deliver optimum health opportunities for patients through uncompromised performance, comfort and safety features.

At Canon Medical, we work hand in hand with our partners – our medical, academic and research community. We build relationships based on transparency, trust and respect. Together as one, we strive to create industry-leading solutions that deliver an enriched quality of life.

Masimo Announces Agreement to Acquire TNI medical AG

Masimo Announces Agreement to Acquire TNI medical AG

Masimo a global leader in innovative noninvasive monitoring technologies, announced it has entered into a definitive agreement to acquire TNI medical AG , an innovative ventilation company headquartered in Würzburg, Germany. In August 2019, Masimo disclosed an investment in TNI that included an exclusive option to acquire the company.

TNI’s novel softFlow technology is designed to provide high flow, warmed and humidified respiratory gases to spontaneously breathing patients suffering from serious pulmonary conditions. The softFlow technology provides efficient, quiet and comfortable respiratory support by generating a precisely regulated, stable high flow of room air or a mix of room air and oxygen. The system, comprised of an integrated flow generator, respiratory circuit, and patient interface, operates without the need of pneumatic systems (i.e. compressed air supplied from the hospital wall) and can be used both in the hospital and at home.

Ewald Anger, CEO of TNI, said, “The TNI team is excited to join Masimo and leverage their deep engineering and commercial expertise to continue delivering our technology to a large and growing global market for therapy with nasal insufflation.”

“We have been closely monitoring TNI since Masimo made its investment last summer and are thrilled to see the tremendous progress they have made in such a short time,” said Joe Kiani, Founder, Chairman, and CEO of Masimo. “Due to COVID-19, there has been increasing demand for TNI’s softFlow technology. We decided to exercise our option to acquire the company well before the option expired to allow Masimo to scale manufacturing. We believe this technology will provide clinicians with important additional tools to address the growing number of people affected by pulmonary diseases and respiratory-related illnesses, including those suffering from COVID-19. This acquisition illustrates our commitment to improving patient outcomes and reducing the cost of care.”

The transaction is expected to close in the second quarter of 2020, subject to customary closing conditions. Masimo expects to fund the acquisition with existing cash on hand and expects the transaction to have an immaterial impact to net earnings in 2020.

About Masimo

Masimo is a global medical technology company that develops and produces a wide array of industry-leading monitoring technologies, including innovative measurements, sensors, patient monitors, and automation and connectivity solutions. Our mission is to improve patient outcomes and reduce the cost of care. Masimo SET® Measure-through Motion and Low Perfusion™ pulse oximetry, introduced in 1995, has been shown in over 100 independent and objective studies to outperform other pulse oximetry technologies.1 Masimo SET® has also been shown to help clinicians reduce severe retinopathy of prematurity in neonates,2 improve CCHD screening in newborns,3 and, when used for continuous monitoring with Masimo Patient SafetyNet™ in post-surgical wards, reduce rapid response team activations, ICU transfers, and costs.4-6 Masimo SET® is estimated to be used on more than 200 million patients in leading hospitals and other healthcare settings around the world,7 and is the primary pulse oximetry at 9 of the top 10 hospitals listed in the 2019-20 U.S. News and World Report Best Hospitals Honor Roll.8 Masimo continues to refine SET® and in 2018, announced that SpO2 accuracy on RD SET® sensors during conditions of motion has been significantly improved, providing clinicians with even greater confidence that the SpO2 values they rely on accurately reflect a patient’s physiological status. In 2005, Masimo introduced rainbow® Pulse CO-Oximetry technology, allowing noninvasive and continuous monitoring of blood constituents that previously could only be measured invasively, including total hemoglobin (SpHb®), oxygen content (SpOC™), carboxyhemoglobin (SpCO®), methemoglobin (SpMet®), Pleth Variability Index (PVi®), RPVi™ (rainbow® PVi), and Oxygen Reserve Index (ORi™). In 2013, Masimo introduced the Root® Patient Monitoring and Connectivity Platform, built from the ground up to be as flexible and expandable as possible to facilitate the addition of other Masimo and third-party monitoring technologies; key Masimo additions include Next Generation SedLine® Brain Function Monitoring, O3® Regional Oximetry, and ISA™ Capnography with NomoLine® sampling lines. Masimo’s family of continuous and spot-check monitoring Pulse CO-Oximeters® includes devices designed for use in a variety of clinical and non-clinical scenarios, including tetherless, wearable technology, such as Radius-7® and Radius PPG™, portable devices like Rad-67™, fingertip pulse oximeters like MightySat® Rx, and devices available for use both in the hospital and at home, such as Rad-97®. Masimo hospital automation and connectivity solutions are centered around the Iris® platform, and include Iris Gateway®, Patient SafetyNet, Replica™, Halo ION™, UniView™, and Doctella™

Doctors Equipped with Telehealth Technology to Help Alleviate COVID-19 Pressures

Doctors Equipped with Telehealth Technology to Help Alleviate COVID-19 Pressures

Equality Health, a Phoenix-based whole-health delivery system, announces an initiative to support primary care practices – a need accelerated by the novel coronavirus pandemic. Starting this week, the company will roll out a telehealth solution, connectivity and technical support services at no cost to more than 1,300 Arizona-based primary care providers in the network to help them ‘virtually’ triage sick patients and provide ongoing care to their entire patient population. The move offers benefit to all patients, particularly those with chronic conditions and individuals facing barriers to accessing care. The easy-to-use telehealth tool allows doctors the means to see more patients in a timely and safe manner in the midst of a call for social distancing and voluntary quarantine.

“Clinicians and their patients will be able to manage an array of health conditions, acute and chronic, securely and privately without having to travel to the doctor’s office,” said Dr. Mark Stephan, Chief Medical Officer of Equality Health. “Telehealth technology is not new, but now we’re putting the tool in the hands of the primary care provider. They have the patient’s historical record. They know the patient’s family. They have the patient’s trust.”

“Equality Health is committed to helping providers reduce the community spread of COVID-19 and keep our most vulnerable populations safe and healthy,” said Hugh Lytle, Founder, Chairman and CEO of Equality Health. “We are giving primary care practices actionable information, new and innovative tools and additional practice support to take care of their patients.” Supplying independent physician practices with software, plus operational and technical support to care for their patients helps them deliver timely, essential healthcare services and remain financially secure.

Patients can securely connect online, even in low-bandwidth environments, using their cellphone or computer. The HIPAA compliant tool is easily downloaded at no cost and is available to the practice’s entire population of patients. It is ideal for individuals who are at risk due to underlying health conditions or who struggle with access to care due to lack of transportation, socioeconomic issues or other barriers. The government’s recommendation to remain at home except for essential needs, plus the reasonable fear of contagion, means that many individuals may delay or skip health care visits unless they have access to telehealth services.

Physicians are already working with Equality Health to integrate this telehealth solution into their practices. The company is also providing ongoing training and support as well as coding/billing education to ensure it works for each practice.

About Equality Health

Equality Health, LLC is a Phoenix-based whole-health delivery system focused on improving access, quality, and member trust. Through a value-based care technology and community resources platform, culturally competent provider network and population-specific care model, Equality Health helps managed care plans and health systems improve care for diverse populations while simultaneously making the transition to risk-based accountability.

Co-Diagnostics JV CoSara First Indian Company to Receive License for COVID-19 Diagnostic

Co-Diagnostics JV CoSara First Indian Company to Receive License for COVID-19 Diagnostic

Co-Diagnostics, Inc., a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests, announced that CoSara Diagnostics Pvt Ltd (“CoSara,” or the “JV”), its joint venture for manufacturing in India, has become the first and only Indian company to receive a license from the Central Drugs Standards Control Organisation (CDSCO) to manufacture RT-PCR COVID-19 test kits. The kits are expected to be sold in the Indian market, as well as for export to the surrounding regions.

CoSara has aligned itself with the “Make in India” initiative introduced in 2014 to transform India into a global design and manufacturing hub, and senior officials from the health department expedited the approval process for the license. The country took early measures to recall its citizens, drastically limit travel into the country and eventually close the country’s borders, which has also increased the demand for indigenous COVID-19 tests to serve India’s population of 1.3 billion.

The outbreak has been declared an epidemic in several states where provisions of the Epidemic Diseases Act have been invoked, and educational institutions and many commercial establishments have been shut down. Prime Minister Narendra Modi also recently called for enhanced testing facilities in an effort to contain the spread of the disease in a country where social isolation, as practiced in other areas, may prove difficult due to the high population density. According to economists, if the pandemic in India grows out-of-control, the consequences are likely to be even more severe than in Italy.

The COVID-19 test kits approved by the CDSCO were those originally designed by Co-Diagnostics, the first U.S. company to receive a CE marking for a COVID-19 diagnostic. “The high-quality tests built on our patented CoPrimer™ technology will have a positive impact on what is projected to be the largest healthcare market in the world,” said Dwight Egan, CEO of Co-Diagnostics. “Co-Diagnostics is honored that our joint venture has achieved such a significant milestone.”

Mohal Sarabhai, Director of CoSara, remarked “Presently there are 52 government-approved testing facilities and delivering the kits to those is the first target,” in addition to pursuing 60 accredited private labs to conduct COVID-19 tests. “Overall, our target market will be private as well as government labs.”

How does science take care of a healthy relationship for black couples

healthy relationship for black couples

Dating black people has never been easier when you use an online dating site. Yet, it’s still worth looking into what science says about how to have a healthy dating experience with fellow black people. Myblackpartner.com has shared a collection of scientific and technological facts that help black couples build relationships Check out the latest information on how to create satisfying relationships.

1. Do technologies effect on relationship healthy black couples?

The first thing that we have to look at is how the science of technology is making black relationships better. There are several things that have been detrimental to black people trying to find love in the past. Most of the time, the greatest threats to black love is when people are antagonizing them, social constraints are in place, and when a vast distance exists between people in love. Fortunately, online dating is something that has solved all of those problems in different ways. With the technology that exists now, black people are able to find people that share their cultural heritage and desires for the future. That gives them the best chance to start a healthy relationship while meeting someone that has a lot in common with them. Technology bridges the gaps, protects people from naysayers and gives people the emotional connection required to have a great dating experience.

2. Chemistry of the brain in a happy relationship

The chemistry of the brain has a lot to do with the appearance of a relationship and whether it lasts. Of course, this is not unique to black people even though the study we’re looking at is very diverse with 166 different cultures studied. The study found that the majority of people that were in a new relationship began in a state of passion and anxiety. They didn’t know if the other partner liked them back as much, they worried over the state of their dating outcomes, and they had no idea if it was going to last. That went away within two years, but the love and passion were left intact. Compassionate love, the kind that lasts, lacks the passion of the first years of dating where there is a bond that appears unbreakable. However, it’s stronger and it helps people over the long-term as they still produced dopamine when having good experiences and oxytocin when things were getting physical in the relationship. All in all, high levels of dopamine diminish over time, but that doesn’t mean that a relationship won’t remain happy!

3. Integration of therapeutic technologies to help improve communication among black partners

There are numerous technologies that can help improve communication among black partners. Using one’s smartphone, email, and dating website profile can help people throttle their relationship to a manageable level that will help it endure. One of the greatest issues with early love is that it is almost too strong. People fall hard in love and the anxiety of the relationship, the fear of letting yourself get too comfortable, is too strong. However, if you can separate yourself from the relationship’s worst elements like not finding time to get together, communicating infrequently, and more, then you’ll have the opportunity to build a successful relationship. Technology is the great equalizer of sorts, and it can help black people find partners in a safe, secure, and fun place.

Black men and women have a difficult time finding partners in the world today. However, the biggest issue that people face is one of communication. Using an online dating site, people can connect with other individuals from their culture with a minimal effort on their part. Moreover, using a dating site can help people maintain the positive aspects of their early relationships while holding back some of the negatives. As demonstrated, the brain chemistry of people that are newly in love can be very beneficial to the strength of the relationship down the line. However, it’s difficult when you’re going through it. A dating website provides a buffer between people that will help them get the results they want without the anxiety and pressure that can cause an otherwise healthy relationship to fail. All in all, dating online is a great way for black people to get romances.

Nebraska Health Information Initiative Taps NextGate for Statewide Patient Matching and Trusted Data Exchange

Nebraska Health Information Initiative Taps NextGate for Statewide Patient Matching and Trusted Data Exchange

NextGate, the global leader in healthcare enterprise identification, announced that the Nebraska Health Information Initiative (NEHII), a leading health information exchange (HIE) connecting over 70 percent of providers in Nebraska, has selected its cloud-based Enterprise Master Patient Index (EMPI) to facilitate accurate patient matching and identification across the state.

The EMPI will integrate clinical information from 300 participating organizations to deliver a trusted network of unified health records for more than 4 million patients receiving care in Nebraska and the surrounding region.

As a strategic component for statewide outcomes improvements and coordination of care, the implementation will enable real-time interoperability and patient data matching for NEHII’s physician, hospital, health plan and pharmacy members. NEHII is the latest HIE organization to implement NextGate’s market-leading EMPI to overcome fragmented, highly diverse EHR applications and empower its network participants with a single best care record.

In the transition to value-based payment and care delivery models, the need for a complete and accurate view of individuals across the healthcare landscape becomes increasingly critical for greater clinical, operational and financial performance. Inaccurate patient identification costs the U.S. healthcare system $6 billion annually and results in medical errors, data quality issues, administrative waste, and poor patient and provider satisfaction.

Central to NEHII’s vision to be the population health utility for the state was to find a patient identity management partner that would eliminate silos of information and deliver a complete picture of a patient’s medical history.

“We are proud to be working with NextGate to ensure our members have meaningful data insights at the point of care to treat patients uniquely across the state,” said Jamie Bland, CEO of NEHII. “Effective care management and collaboration requires fluid data exchange and a holistic view of individuals to make better decisions, understand our populations and deliver the high-quality level of care every resident deserves. With NextGate, we are building a trusted and fully integrated information network that will positively influence the health and well-being of our communities.”

The EMPI will also enhance the state’s prescription drug monitoring program (PDMP), administered by NEHII, to improve patient data accuracy, reduce fraud, support interstate data sharing and match consumers to their medication records.

“HIEs are the lifeblood of state-wide connectivity and data-rich insights for various healthcare constituents across the continuum,” said Andy Aroditis, CEO of NextGate. “We commend NEHII for prioritizing patient identification as the basis for interoperability and are honored to support their population health strategy with a fully-integrated, automated solution that consistently and safely matches individuals to their health data.”

About Nebraska Health Information Initiative (NEHII)

NEHII, Inc is a 501(c)3 non-profit organization with a public/private governance model that includes health care providers, payers and the State of Nebraska. NEHII’s purpose is to achieve health care transformation through community betterment collaboration while protecting the security and privacy of medical information.

About NextGate

With over 200 customers in four countries, NextGate is the global leader in healthcare enterprise identification. Committed to helping organizations overcome the clinical, operational and financial challenges that result from duplicate records and disparate data, our full suite of identity matching solutions connects the entire healthcare ecosystem to drive critical improvements in quality, efficiency and safety. NextGate’s market-leading EMPI currently manages more than 300 million lives and is deployed by the nation’s most successful healthcare systems and health information exchanges.

Translate »